Electrical Equipment & Parts
Compare Stocks
5 / 10Stock Comparison
OESX vs ARAY vs ISRG vs LEDS vs SYK
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Devices
Medical - Instruments & Supplies
Semiconductors
Medical - Devices
OESX vs ARAY vs ISRG vs LEDS vs SYK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Electrical Equipment & Parts | Medical - Devices | Medical - Instruments & Supplies | Semiconductors | Medical - Devices |
| Market Cap | $33M | $35M | $161.07B | $17M | $112.69B |
| Revenue (TTM) | $81M | $429M | $10.58B | $44M | $25.12B |
| Net Income (TTM) | $-5M | $-46M | $2.98B | $-1M | $3.25B |
| Gross Margin | 29.9% | 26.8% | 66.3% | 4.9% | 63.5% |
| Operating Margin | -4.3% | -5.1% | 30.5% | -4.5% | 22.4% |
| Forward P/E | — | — | 43.8x | — | 19.6x |
| Total Debt | $10M | $176M | $303M | $4M | $14.86B |
| Cash & Equiv. | $6M | $57M | $3.37B | $3M | $4.01B |
OESX vs ARAY vs ISRG vs LEDS vs SYK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Orion Energy System… (OESX) | 100 | 20.6 | -79.4% |
| Accuray Incorporated (ARAY) | 100 | 14.0 | -86.0% |
| Intuitive Surgical,… (ISRG) | 100 | 234.6 | +134.6% |
| SemiLEDs Corporation (LEDS) | 100 | 69.8 | -30.2% |
| Stryker Corporation (SYK) | 100 | 150.3 | +50.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: OESX vs ARAY vs ISRG vs LEDS vs SYK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
OESX ranks third and is worth considering specifically for momentum.
- +31.2% vs ARAY's -78.4%
Among these 5 stocks, ARAY doesn't own a clear edge in any measured category.
ISRG is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- 5.5% 10Y total return vs SYK's 187.1%
- Lower volatility, beta 1.02, Low D/E 1.7%, current ratio 4.87x
- 28.2% margin vs ARAY's -10.8%
- 14.8% ROA vs ARAY's -10.1%, ROIC 15.0% vs 3.0%
LEDS is the clearest fit if your priority is growth exposure.
- Rev growth 7.3%, EPS growth 53.1%, 3Y rev CAGR 82.7%
- 7.3% revenue growth vs OESX's -12.0%
SYK carries the broadest edge in this set and is the clearest fit for income & stability and valuation efficiency.
- Dividend streak 34 yrs, beta 0.55, yield 1.1%
- PEG 1.32 vs ISRG's 2.01
- Beta 0.55, yield 1.1%, current ratio 1.89x
- Lower P/E (19.6x vs 43.8x), PEG 1.32 vs 2.01
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.3% revenue growth vs OESX's -12.0% | |
| Value | Lower P/E (19.6x vs 43.8x), PEG 1.32 vs 2.01 | |
| Quality / Margins | 28.2% margin vs ARAY's -10.8% | |
| Stability / Safety | Beta 0.55 vs ARAY's 2.42, lower leverage | |
| Dividends | 1.1% yield; 34-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +31.2% vs ARAY's -78.4% | |
| Efficiency (ROA) | 14.8% ROA vs ARAY's -10.1%, ROIC 15.0% vs 3.0% |
OESX vs ARAY vs ISRG vs LEDS vs SYK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
OESX vs ARAY vs ISRG vs LEDS vs SYK — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ISRG leads in 3 of 6 categories
ARAY leads 1 • SYK leads 1 • OESX leads 0 • LEDS leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ISRG leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SYK is the larger business by revenue, generating $25.1B annually — 566.7x LEDS's $44M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to ARAY's -10.8%. On growth, LEDS holds the edge at +103.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $81M | $429M | $10.6B | $44M | $25.1B |
| EBITDAEarnings before interest/tax | -$1M | -$15M | $3.8B | -$1M | $6.3B |
| Net IncomeAfter-tax profit | -$5M | -$46M | $3.0B | -$1M | $3.2B |
| Free Cash FlowCash after capex | $348M | -$28M | $2.8B | $2M | $4.3B |
| Gross MarginGross profit ÷ Revenue | +29.9% | +26.8% | +66.3% | +4.9% | +63.5% |
| Operating MarginEBIT ÷ Revenue | -4.3% | -5.1% | +30.5% | -4.5% | +22.4% |
| Net MarginNet income ÷ Revenue | -5.6% | -10.8% | +28.2% | -3.0% | +12.9% |
| FCF MarginFCF ÷ Revenue | +4.3% | -6.5% | +26.8% | +5.1% | +17.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.7% | -7.4% | +23.0% | +103.7% | +11.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +109.6% | -6.1% | +18.8% | -18.7% | +56.0% |
Valuation Metrics
ARAY leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 35.0x trailing earnings, SYK trades at a 39% valuation discount to ISRG's 57.6x P/E. Adjusting for growth (PEG ratio), SYK offers better value at 2.36x vs ISRG's 2.65x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $33M | $35M | $161.1B | $17M | $112.7B |
| Enterprise ValueMkt cap + debt − cash | $37M | $154M | $158.0B | $18M | $123.5B |
| Trailing P/EPrice ÷ TTM EPS | -2.57x | -18.91x | 57.62x | -13.53x | 35.03x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 43.84x | — | 19.62x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 2.65x | — | 2.36x |
| EV / EBITDAEnterprise value multiple | — | 10.99x | 43.62x | — | 20.31x |
| Price / SalesMarket cap ÷ Revenue | 0.41x | 0.08x | 16.00x | 0.39x | 4.49x |
| Price / BookPrice ÷ Book value/share | 2.56x | 0.37x | 9.17x | 5.64x | 5.02x |
| Price / FCFMarket cap ÷ FCF | 66.51x | — | 64.67x | 10.16x | 26.31x |
Profitability & Efficiency
ISRG leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-77 for ARAY. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to ARAY's 2.17x. On the Piotroski fundamental quality scale (0–9), ARAY scores 6/9 vs OESX's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -0.0% | -77.5% | +16.9% | -64.0% | +15.0% |
| ROA (TTM)Return on assets | -0.0% | -10.1% | +14.8% | -9.3% | +6.9% |
| ROICReturn on invested capital | -34.8% | +3.0% | +15.0% | -24.9% | +11.4% |
| ROCEReturn on capital employed | -34.9% | +2.8% | +16.5% | -38.3% | +13.0% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 6 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.87x | 2.17x | 0.02x | 1.44x | 0.66x |
| Net DebtTotal debt minus cash | $4M | $119M | -$3.1B | $1M | $10.8B |
| Cash & Equiv.Liquid assets | $6M | $57M | $3.4B | $3M | $4.0B |
| Total DebtShort + long-term debt | $10M | $176M | $303M | $4M | $14.9B |
| Interest CoverageEBIT ÷ Interest expense | -3.29x | -1.86x | — | -14.59x | 6.72x |
Total Returns (Dividends Reinvested)
ISRG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ISRG five years ago would be worth $15,873 today (with dividends reinvested), compared to $606 for ARAY. Over the past 12 months, OESX leads with a +31.2% total return vs ARAY's -78.4%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.4% vs ARAY's -56.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -38.0% | -65.5% | -19.3% | +25.3% | -15.2% |
| 1-Year ReturnPast 12 months | +31.2% | -78.4% | -15.4% | -6.0% | -22.5% |
| 3-Year ReturnCumulative with dividends | -38.7% | -91.8% | +49.6% | +0.7% | +5.5% |
| 5-Year ReturnCumulative with dividends | -83.6% | -93.9% | +58.7% | -74.5% | +21.5% |
| 10-Year ReturnCumulative with dividends | -32.5% | -94.5% | +554.2% | +9.7% | +187.1% |
| CAGR (3Y)Annualised 3-year return | -15.1% | -56.6% | +14.4% | +0.2% | +1.8% |
Risk & Volatility
Evenly matched — ISRG and SYK each lead in 1 of 2 comparable metrics.
Risk & Volatility
SYK is the less volatile stock with a 0.55 beta — it tends to amplify market swings less than ARAY's 2.42 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ISRG currently trades 75.1% from its 52-week high vs ARAY's 14.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.10x | 2.42x | 1.02x | 1.91x | 0.55x |
| 52-Week HighHighest price in past year | $18.64 | $2.10 | $603.88 | $3.37 | $404.87 |
| 52-Week LowLowest price in past year | $5.50 | $0.28 | $427.84 | $1.01 | $289.91 |
| % of 52W HighCurrent price vs 52-week peak | +49.6% | +14.0% | +75.1% | +60.2% | +72.7% |
| RSI (14)Momentum oscillator 0–100 | 41.8 | 58.4 | 42.4 | 73.5 | 24.3 |
| Avg Volume (50D)Average daily shares traded | 39K | 1.4M | 1.8M | 23K | 2.1M |
Analyst Outlook
SYK leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: ISRG as "Buy", SYK as "Buy". Consensus price targets imply 37.3% upside for ISRG (target: $623) vs 37.2% for SYK (target: $404). SYK is the only dividend payer here at 1.14% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | — | Buy |
| Price TargetConsensus 12-month target | — | — | $622.60 | — | $403.69 |
| # AnalystsCovering analysts | — | — | 55 | — | 50 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +1.1% |
| Dividend StreakConsecutive years of raises | 1 | — | — | — | 34 |
| Dividend / ShareAnnual DPS | — | — | — | — | $3.36 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.0% | 0.0% | +1.4% | 0.0% | 0.0% |
ISRG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ARAY leads in 1 (Valuation Metrics). 1 tied.
OESX vs ARAY vs ISRG vs LEDS vs SYK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is OESX or ARAY or ISRG or LEDS or SYK a better buy right now?
For growth investors, SemiLEDs Corporation (LEDS) is the stronger pick with 729.
8% revenue growth year-over-year, versus -12. 0% for Orion Energy Systems, Inc. (OESX). Stryker Corporation (SYK) offers the better valuation at 35. 0x trailing P/E (19. 6x forward), making it the more compelling value choice. Analysts rate Intuitive Surgical, Inc. (ISRG) a "Buy" — based on 55 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — OESX or ARAY or ISRG or LEDS or SYK?
On trailing P/E, Stryker Corporation (SYK) is the cheapest at 35.
0x versus Intuitive Surgical, Inc. at 57. 6x. On forward P/E, Stryker Corporation is actually cheaper at 19. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Stryker Corporation wins at 1. 32x versus Intuitive Surgical, Inc. 's 2. 01x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — OESX or ARAY or ISRG or LEDS or SYK?
Over the past 5 years, Intuitive Surgical, Inc.
(ISRG) delivered a total return of +58. 7%, compared to -93. 9% for Accuray Incorporated (ARAY). Over 10 years, the gap is even starker: ISRG returned +554. 2% versus ARAY's -94. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — OESX or ARAY or ISRG or LEDS or SYK?
By beta (market sensitivity over 5 years), Stryker Corporation (SYK) is the lower-risk stock at 0.
55β versus Accuray Incorporated's 2. 42β — meaning ARAY is approximately 342% more volatile than SYK relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 2% for Accuray Incorporated — giving it more financial flexibility in a downturn.
05Which is growing faster — OESX or ARAY or ISRG or LEDS or SYK?
By revenue growth (latest reported year), SemiLEDs Corporation (LEDS) is pulling ahead at 729.
8% versus -12. 0% for Orion Energy Systems, Inc. (OESX). On earnings-per-share growth, the picture is similar: Accuray Incorporated grew EPS 90. 3% year-over-year, compared to 0. 0% for Orion Energy Systems, Inc.. Over a 3-year CAGR, LEDS leads at 82. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — OESX or ARAY or ISRG or LEDS or SYK?
Intuitive Surgical, Inc.
(ISRG) is the more profitable company, earning 28. 4% net margin versus -14. 8% for Orion Energy Systems, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -13. 3% for OESX. At the gross margin level — before operating expenses — ISRG leads at 66. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is OESX or ARAY or ISRG or LEDS or SYK more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Stryker Corporation (SYK) is the more undervalued stock at a PEG of 1. 32x versus Intuitive Surgical, Inc. 's 2. 01x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Stryker Corporation (SYK) trades at 19. 6x forward P/E versus 43. 8x for Intuitive Surgical, Inc. — 24. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ISRG: 37. 3% to $622. 60.
08Which pays a better dividend — OESX or ARAY or ISRG or LEDS or SYK?
In this comparison, SYK (1.
1% yield) pays a dividend. OESX, ARAY, ISRG, LEDS do not pay a meaningful dividend and should not be held primarily for income.
09Is OESX or ARAY or ISRG or LEDS or SYK better for a retirement portfolio?
For long-horizon retirement investors, Stryker Corporation (SYK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
55), 1. 1% yield, +187. 1% 10Y return). Accuray Incorporated (ARAY) carries a higher beta of 2. 42 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SYK: +187. 1%, ARAY: -94. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between OESX and ARAY and ISRG and LEDS and SYK?
These companies operate in different sectors (OESX (Industrials) and ARAY (Healthcare) and ISRG (Healthcare) and LEDS (Technology) and SYK (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: OESX is a small-cap quality compounder stock; ARAY is a small-cap quality compounder stock; ISRG is a mid-cap high-growth stock; LEDS is a small-cap high-growth stock; SYK is a mid-cap quality compounder stock. SYK pays a dividend while OESX, ARAY, ISRG, LEDS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.